Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical study evaluating the efficacy and safety of combining cilostazol and probucol in patients with diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Cilostazol (Cilostazol)
• Probucol (Probucol)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Diabetic Nephropathy | Phase 4 | Status: COMPLETED